Does a 1.1‑cm adrenal adenoma require a work‑up (hormonal screening and imaging follow‑up)?

Does a 1.1 cm Adrenal Adenoma Require Work-Up?

Yes, a 1.1 cm adrenal adenoma requires hormonal screening but may not require imaging follow-up depending on its radiologic characteristics. 1

Initial Evaluation Framework

According to the 2023 CUA/AUA guidelines, all adrenal incidentalomas ≥1 cm require initial assessment through two parallel pathways: radiologic characterization and hormonal screening 1.

Radiologic Assessment

The first critical step is obtaining a non-contrast CT if not already performed 1. The Hounsfield Unit (HU) measurement determines the subsequent pathway:

• HU ≤10: This is a benign lipid-rich adenoma with 0% malignancy risk. No further imaging follow-up is required regardless of size 1, 2
• HU 11-20: Indeterminate lesion with 0.5% malignancy risk; requires additional imaging (washout CT or chemical-shift MRI) 1
• HU >20: Suspicious lesion with 6.3% malignancy risk; requires multidisciplinary discussion 1

Important caveat: Recent evidence suggests that for true incidentalomas <4 cm, expanding the benignity threshold to ≤20 HU may maintain 99.4-99.8% positive predictive value for benignity 3. However, current guidelines remain conservative at ≤10 HU.

Mandatory Hormonal Screening

All patients with adrenal incidentalomas ≥1 cm require comprehensive hormonal evaluation 1, 4. This is non-negotiable because approximately 27.5-40% of incidentalomas are functional 5, 4, and hormonal excess significantly impacts morbidity and mortality.

Required Tests:

1. Autonomous cortisol secretion screening (all patients):

   • 1-mg overnight dexamethasone suppression test (preferred method) 1
   • Cutoff: serum cortisol >50 nmol/L (>1.8 µg/dL) indicates mild autonomous cortisol secretion (MACS) 6
   • MACS affects 20-50% of incidentalomas and increases cardiovascular event rates to 15.5% over 50-60 months 3

2. Primary aldosteronism screening (if hypertension and/or hypokalemia present):

   • Aldosterone-to-renin ratio 1

3. Pheochromocytoma screening:

   • Skip if: HU <10 on unenhanced CT AND no signs/symptoms of adrenergic excess (headaches, palpitations, sweating, anxiety) 1
   • Perform if: HU >10 OR any adrenergic symptoms present
   • Test: plasma or 24-hour urinary metanephrines 1

4. Androgen testing (only if virilization signs present or suspected adrenocortical carcinoma) 1

Clinical History and Physical Examination

Focus specifically on:

• Hypercortisolism: Weight gain, central obesity, easy bruising, purple striae >1 cm, proximal muscle weakness, facial plethora 1
• Primary aldosteronism: Hypertension, hypokalemia, muscle cramping 1
• Pheochromocytoma: Episodic headaches, sweating, palpitations, severe hypertension, family history of MEN2/VHL/neurofibromatosis 1
• Malignancy: Flank pain, weight loss, history of extra-adrenal cancer 1

Follow-Up Imaging Decision

For your 1.1 cm adenoma specifically:

• If HU ≤10 and non-functional: No further imaging follow-up required 1
• If HU 11-20: Obtain second-line imaging (washout CT or MRI), then follow if remains indeterminate 1, 2
• If HU >20: Multidisciplinary discussion; likely requires 6-12 month follow-up imaging 2

Common Pitfalls to Avoid

1. Do not skip hormonal screening even if imaging appears benign—imaging cannot reliably exclude functional tumors 1
2. Never biopsy an adrenal mass without first excluding pheochromocytoma (risk of hypertensive crisis) 1
3. Be aware that approximately 1/3 of pheochromocytomas can show benign washout characteristics on CT 1
4. Do not assume bilateral lesions are the same pathology—each requires individual characterization 2

Summary Algorithm for 1.1 cm Adrenal Adenoma

1. Obtain non-contrast CT (if not done) → measure HU
2. Perform hormonal screening: 1-mg dexamethasone suppression test (all patients), aldosterone-to-renin ratio (if hypertensive), metanephrines (if HU >10 or symptoms)
3. If HU ≤10 and non-functional: Work-up complete, no follow-up needed
4. If HU >10 or functional: Additional imaging and/or multidisciplinary discussion required

1, 2